Ccn5 Gene Therapy Reduces Myocardial Infarction Size and Improves Contractility in Ischemic Cardiomyopathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Dongtak | - |
dc.contributor.author | Yoo, Jimeen | - |
dc.contributor.author | Song, Min Ho | - |
dc.contributor.author | Gubara, Sarah M. | - |
dc.contributor.author | Katz, Michael G. | - |
dc.contributor.author | Park, Woo Jin | - |
dc.contributor.author | Fargnoli, Anthony | - |
dc.date.accessioned | 2021-06-22T09:25:23Z | - |
dc.date.available | 2021-06-22T09:25:23Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 0009-7322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/2031 | - |
dc.description.abstract | Introduction: Salvaging ischemic myocardium post acute myocardial (MI) infarction has not been achieved with current treatments. Gene therapy via adeno-associated virus (AAV) offers a promising strategy since myocytes can be reprogrammed fast after MI. CCN5 is a pleiotropic target shown to rescue function and reduce fibrosis in murine models. CCN5’s mode of action is 2 fold: upregulating survival and reducing fibrosis mechanisms. Here, we attempt to validate CCN5 in a sheep MI model. Hypothesis: CCN5 will salvage post MI myocardium and improve extracellular matrix composition through reducing levels of: TGFB signalling, myofibroblasts and collagen I deposition. Methods: Surgical ligation of 2 arteries was performed in n=12 sheep and randomized between AAV9 null or AAV9 CCN5. 30 min after MI, 15 single AAV injections were given in the MI area, total 1 x 1013. MRI assessed function at 1 and 3 months. Assays: QPCR of genome copies, CCN5 expression, TGFB ELISA, collagen I and histology. Results: CCN5 reduced MI size to [7±2%] F1A as compared with nulls F1B [18±2%] at 3 months. LV Ejection fraction was preserved with CCN5 [50±4%] compared to heart failure in the nulls [36±3%] F1C. End Systolic volumes were higher in the nulls [84±6mL] in to CCN5 [52±4mL] F1D. QPCR of AAV.CCN5 detected 995086 GC per 1 ug DNA or 8.1 GC/cell in the injected zones, but not distal areas. Cardiac specific CCN5 expression confirmed via confocal Fig1E and western blot. TGFB levels were significantly less in CCN5 treated samples [0.67±0.2AU] to nulls’s areas [1.6±0.3AU]. FACS cell sorting revealed significantly less myofibroblast detection range 0.2-4% for CCN5 samples versus >20% for nulls Fig1F. Collagen I (red) stain revealed significantly less formation in CCN5 [3.3±0.05AU] F1G vs high [8.2±0.07AU] in nulls F1H. Conclusions: CCN5 preserves myocytes in the setting of MI and reduces chronic fibrosis markers. CCN5 gene therapy could be a treatment option for early stage MI or cardiac surgery indications. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Ccn5 Gene Therapy Reduces Myocardial Infarction Size and Improves Contractility in Ischemic Cardiomyopathy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jeong, Dongtak | - |
dc.identifier.doi | 10.1161/CIRC.140.SUPPL_1.12996 | - |
dc.identifier.wosid | 000529998003115 | - |
dc.identifier.bibliographicCitation | Circulation, v.140, no.suppl.1, pp.p A12996 - p A12996 | - |
dc.relation.isPartOf | Circulation | - |
dc.citation.title | Circulation | - |
dc.citation.volume | 140 | - |
dc.citation.number | suppl.1 | - |
dc.citation.startPage | p A12996 | - |
dc.citation.endPage | p A12996 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.identifier.url | https://oce.ovid.com/article/00003017-201911191-01648/HTML | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.